Azenta, Inc. logo

Azenta, Inc. (BA3)

Market Closed
12 Dec, 20:00
XDUS XDUS
30. 20
-1.6
-5.03%
- Market Cap
- P/E Ratio
0.4% Div Yield
0 Volume
- Eps
31.8
Previous Close
Day Range
30.2 31.6
Year Range
21.2 52.5
Want to track BA3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 52 days

Summary

BA3 closed today lower at €30.2, a decrease of 5.03% from yesterday's close, completing a monthly increase of 0.67% or €0.2. Over the past 12 months, BA3 stock lost -36.82%.
BA3 pays dividends to its shareholders, with the most recent payment made on Dec 23, 2021. The next estimated payment will be in 23 Mar 2022 on Mar 23, 2022 for a total of €0.1.
The last earnings report, released on Nov 21, 2025, missed the consensus estimates by -0.21%. On average, the company has fell short of earnings expectations by -0.11%, based on the last three reports. The next scheduled earnings report is due on Feb 03, 2026.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

BA3 Chart

Azenta, Inc. (AZTA) Analyst/Investor Day Transcript

Azenta, Inc. (AZTA) Analyst/Investor Day Transcript

Azenta, Inc. (AZTA) Analyst/Investor Day Transcript

Seekingalpha | 2 days ago
New Strong Sell Stocks for December 9th

New Strong Sell Stocks for December 9th

BRBR, AZTA and BRDCY have been added to the Zacks Rank #5 (Strong Sell) List on December 9, 2025.

Zacks | 4 days ago
Azenta, Inc. (AZTA) Q4 2025 Earnings Call Transcript

Azenta, Inc. (AZTA) Q4 2025 Earnings Call Transcript

Azenta, Inc. ( AZTA ) Q4 2025 Earnings Call November 21, 2025 8:30 AM EST Company Participants Yvonne Perron - Vice President of Financial Planning & Analysis and Investor Relations John P. Marotta - President, CEO & Director Lawrence Lin - Executive VP & CFO Conference Call Participants David Saxon - Needham & Company, LLC, Research Division Steven Etoch - Stephens Inc., Research Division Andrew Cooper - Raymond James & Associates, Inc., Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Jacqueline Kisa - TD Cowen, Research Division Paul Knight - KeyBanc Capital Markets Inc., Research Division Presentation Operator Greetings, and welcome to the Azenta Q4 2025 Financial Results.

Seekingalpha | 3 weeks ago

Azenta, Inc. (BA3) FAQ

What is the stock price today?

The current price is €30.20.

On which exchange is it traded?

Azenta, Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is BA3.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.4%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Feb 03, 2026.

Has Azenta, Inc. ever had a stock split?

No, there has never been a stock split.

Azenta, Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
John P. Marotta CEO
XDUS Exchange
US1143401024 ISIN
US Country
3,000 Employees
2 Dec 2021 Last Dividend
- Last Split
- IPO Date

Overview

Azenta, Inc. offers specialized biological and chemical compound sample management and exploration solutions tailored for the life sciences market globally, including regions such as North America, Africa, China, the United Kingdom, the rest of Europe, and the Asia Pacific. With operations in two key segments - Life Sciences Products and Life Sciences Services - Azenta caters to a wide audience in pharmaceuticals, biotech, healthcare, clinical research, and academic sectors. It has transformed from its original name, Brooks Automation, Inc., reflecting its focus and expertise in life sciences since its establishment in 1978. Based in Burlington, Massachusetts, Azenta has evolved to become a pivotal provider of comprehensive services and products for managing, preserving, and analyzing biological samples and compounds for the life sciences industry.

Products and Services

  • Automated Cold Storage Solutions

    These include advanced storage facilities designed to automate the management of samples at cold temperatures, ensuring their preservation and integrity for long-term research and analysis needs.

  • Consumables and Instruments

    A wide range of essential laboratory consumables and instruments, including vials, tubes, polymerase chain reaction plates, and devices supporting various workflows, all tailored to enhance the efficiency of life sciences research.

  • Controlled Rate Thawing Devices

    Specially designed devices for the controlled thawing of frozen samples to preserve their biological activity and integrity for further analysis or experimentation.

  • Temperature-Controlled Storage and Transportation Solutions

    Offers a suite of solutions for the storage and transport of temperature-sensitive samples, ensuring they remain uncompromised throughout their journey and storage period.

  • Genomic Services

    Comprehensive genomic analysis offerings, including gene sequencing and synthesis services that support the research, discovery, and development processes in life sciences.

  • Sample Repository Solutions

    Services encompassing both on-site and off-site sample storage, cold chain logistics, sample transport, collection relocation, bio-processing solutions, and disaster recovery. Azenta also provides project management and consulting services, underscoring its role as a versatile partner in biospecimen management.

  • Biospecimen Procurement Services

    Reliable procurement of biospecimens tailored to the specific needs of research, development, and clinical studies, facilitating advancements in healthcare and biotechnology.

Contact Information

Address: 15 Elizabeth Drive
Phone: 978 262 2626